Related Experiment Videos
Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis
J Link1, M Söderström, T Olsson
1Department of Neurology, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.
Annals of Neurology
|September 1, 1994
Summary
Multiple sclerosis (MS) involves elevated levels of key cytokines, including interleukin-4 (IL-4), transforming growth factor-beta (TGF-beta), and interferon-gamma (IFN-gamma), detected in patient blood and cerebrospinal fluid. These findings suggest potential therapeutic targets for MS treatment.
Area of Science:
- Neuroimmunology
- Cytokine Biology
Background:
- Multiple sclerosis (MS) is an inflammatory neurological disease.
- The roles of specific immunoregulatory cytokines, such as interferon-gamma (IFN-gamma), interleukin-4 (IL-4), and transforming growth factor-beta (TGF-beta), in MS pathogenesis have been unclear.
Purpose of the Study:
- To investigate the expression of mRNA for IFN-gamma, IL-4, and TGF-beta in mononuclear cells (MNC) from patients with MS and related conditions.
- To correlate cytokine expression levels with disease activity and disability in MS.
Main Methods:
- In situ hybridization using complementary DNA oligonucleotide probes was employed to detect cytokine mRNA.
- MNC were analyzed from the blood and cerebrospinal fluid of patients with MS, optic neuritis, myasthenia gravis, other neurological diseases, and healthy controls.
Main Results:
- Significantly elevated levels of MNC expressing IFN-gamma, IL-4, and TGF-beta mRNA were found in untreated MS and optic neuritis patients compared to controls.
- In MS and optic neuritis, IL-4 mRNA-expressing cells were most abundant, followed by TGF-beta and IFN-gamma.
- MS patients with moderate to severe disability showed high levels of IFN-gamma-positive cells, while those with no or mild disability had high TGF-beta mRNA-expressing cells.
Conclusions:
- The study provides evidence for the involvement of IFN-gamma, IL-4, and TGF-beta in the inflammatory processes of MS.
- IFN-gamma and TGF-beta may exert opposing effects in MS, suggesting that therapies targeting these cytokines, such as inhibiting IFN-gamma and/or promoting TGF-beta, could be beneficial for MS treatment.